Ocular Phenotype and Complications in Patients with Tuberous Sclerosis Complex (TSC)

被引:0
|
作者
Zweipfenning, Florian [1 ]
Toelle, Sandra P. [2 ]
Gerth-Kahlert, Christina [1 ]
机构
[1] Univ Spital Zurich, Augenklin, Frauenklin Str 24, CH-8091 Zurich, Switzerland
[2] Univ Kinderspital Zurich, Abt Neuropadiatrie, Zurich, Switzerland
关键词
tuberous sclerosis complex; inverse optic atrophy; vigabatrin toxicity; RETINAL ASTROCYTOMAS; VIGABATRIN TOXICITY; RECOMMENDATIONS;
D O I
10.1055/a-0804-1816
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background Evaluation and comparison of the ocular phenotype in patients diagnosed with tuberous sclerosis complex (TSC). Analysis of ocular complications during follow-up. Patients and Methods A retrospective chart review was performed of patients with TSC who had received an ocular examination at the eye clinic of the University Hospital Zurich. Data were analysed on visual acuity (VA) assessment, refraction, anterior and posterior eye examination including the distinction of different types of hamartomas and, when available, visual fields. The study was approved by the Cantonal Ethics Committee of Zurich. Results A total of 30 patients who were diagnosed with TSC (19 female, 11 male) were included in the analysis. The age at first examination varied from 7 months to 44 years (mean 13.3 years, standard deviation 11.31). 17/30 patients received a follow-up examination between 4 months and 19 years (mean 4.3 years, standard deviation 5.24). Data of VA were available in 26/30 patients, of whom 22 had normal vision in both eyes. The causes of reduced VA in the 4 patients were: complications of a subependymal giant cell astrocytoma followed by a bilateral optic nerve atrophy; vigabatrin-associated optic atrophy; anterior segment dysgenesis; unilateral amblyopia. Adequate VA testing was not possible in 4 patients because of intellectual disabilities. Retinal hamartomas were described in 15/30 patients: 8 unilateral, 7 bilateral. The flat hamartoma type was described in 10/15 patients, the multinodular type in 6/15 patients. Conclusions The ocular phenotype in our patient cohort shows similar TSC involvement to that described in the literature. Patients diagnosed with TSC require regular ophthalmic examinations to diagnose secondary ocular complications, such as papilloedema, severe vision loss or visual field constriction.
引用
收藏
页码:462 / 468
页数:7
相关论文
共 50 条
  • [1] Quality of life in patients with Tuberous Sclerosis Complex (TSC)
    Amin, Sam
    Mallick, Andrew A.
    Lux, Andrew
    O'Callaghan, Finbar
    [J]. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2019, 23 (06) : 801 - 807
  • [2] Preventive Epilepsy Therapy in Patients with Tuberous Sclerosis Complex (TSC)
    Grigorieva, A. V.
    Dorofeeva, M. Y.
    Gorchkhanova, Z. K.
    Belousova, E. D. G. A. V.
    Dorofeeva, M. Y.
    Gorchkhanova, Z. K.
    Belousova, E. D.
    [J]. EPILEPSIA, 2018, 59 : S291 - S291
  • [3] Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients
    Brakemeier, S.
    Bachmann, F.
    Budde, K.
    [J]. PEDIATRIC NEPHROLOGY, 2017, 32 (07) : 1137 - 1144
  • [4] TSC1 and TSC2: Tuberous Sclerosis Complex and Its Related Epilepsy Phenotype
    Di Napoli, Claudia
    Gennaro, Alessia
    Lupica, Carmelania
    Falsaperla, Raffaele
    Leonardi, Roberta
    Garozzo, Maria Teresa
    Polizzi, Agata
    Pratico, Andrea D.
    Zanghi, Antonio
    Ruggieri, Martino
    [J]. JOURNAL OF PEDIATRIC NEUROLOGY, 2023, 21 (04) : 235 - 247
  • [5] Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients
    S. Brakemeier
    F. Bachmann
    K. Budde
    [J]. Pediatric Nephrology, 2017, 32 : 1137 - 1144
  • [6] A dermatological assessment of pediatric patients with tuberous sclerosis complex (TSC)
    Nunes, Beatriz Azevedo
    Romano, Ana Karolina Ferreira Goncalves
    Morgan, Mariana Aparecida Pasa
    Goncalves, Alice Andrade
    Cardozo, Lais Faria Masulk
    de Almeida, Luiz Gustavo Dufner
    Haddad, Luciana Amaral
    Crippa, Ana Chrystina de Souza
    Antoniuk, Sergio Antonio
    Abagge, Kerstin Taniguchi
    [J]. ANAIS BRASILEIROS DE DERMATOLOGIA, 2024, 99 (05) : 662 - 669
  • [7] Dermatological manifestations of tuberous sclerosis complex (TSC)
    Ebrahimi-Fakhari, Daniel
    Meyer, Sascha
    Vogt, Thomas
    Pfoehler, Claudia
    Mueller, Cornelia Sigrid Lissi
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 (07): : 695 - 701
  • [8] Therapy of Tuberous Sclerosis Complex (TSC): An Update
    Knuf, M.
    Bach, A.
    Lampe, C.
    [J]. AKTUELLE DERMATOLOGIE, 2013, 39 (03) : 74 - 78
  • [9] Family reflections: tuberous sclerosis complex (TSC)
    Shelly Meitzler
    [J]. Pediatric Research, 2021, 89 : 1578 - 1579
  • [10] The Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC)
    Feliciano, David M.
    [J]. FRONTIERS IN NEUROANATOMY, 2020, 14